Livionex Pharma

Livionex Pharma is a commercial-stage biotech company that has developed a patented oral care platform centered on Activated Edathamil, a molecule that breaks the bond between plaque and teeth. The company sells directly to consumers through its website with products like LIVFRESH Dental Gel and Gum Protect+, which are backed by clinical studies and endorsed by dental professionals. While currently focused on the over-the-counter oral hygiene market, its underlying technology platform suggests potential for expansion into prescription dental therapeutics or other drug delivery applications. The company appears to be privately held and revenue-generating, with a strong digital marketing and e-commerce presence.

Patented formulations using Activated Edathamil (EDTA) to chelate calcium and break molecular bonds of dental plaque biofilm, combined with a thixotropic gel for enhanced delivery.

Livionex competes in the premium oral care segment against brands like Colgate Total, Crest Gum Detoxify, Parodontax, and TheraBreath. Its primary differentiation is its patented biochemical mechanism of action and strong clinical data, but it faces competitors with far greater marketing resources and retail shelf space.